Crinetics Pharmaceuticals (CRNX) Other Operating Expenses (2025 - 2026)

Crinetics Pharmaceuticals' Other Operating Expenses history runs 3 years deep, the most recent figure standing at $200000.0 for Q1 2026.

• In Q1 2026, Other Operating Expenses changed N/A year-over-year to $200000.0; the TTM figure through Mar 2026 stood at $55.4 million (changed N/A YoY), while the FY2025 annual figure was $1.1 million, changed N/A from the prior year.
• Other Operating Expenses for Q1 2026 stood at $200000.0, down from $1.1 million in the prior quarter.
• The five-year high for Other Operating Expenses was $98.6 million in Q4 2022, with the low at $200000.0 in Q1 2026.
• The 3-year median for Other Operating Expenses is $27.6 million (2025), against an average of $38.5 million.